Filing Details

Accession Number:
0001261380-16-000114
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-11-17 18:59:00
Reporting Period:
2016-11-16
Filing Date:
2016-11-17
Accepted Time:
2016-11-17 18:59:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1006045 Iridex Corp IRIX Electromedical & Electrotherapeutic Apparatus (3845) 770210467
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1658282 R Romeo Dizon 1212 Terra Bella Avenue
Mountain View CA 94043
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-11-16 334 $5.92 20,434 No 4 M Direct
Common Stock Disposition 2016-11-16 334 $16.04 20,100 No 4 S Direct
Common Stock Acquisiton 2016-11-16 125 $8.58 20,225 No 4 M Direct
Common Stock Disposition 2016-11-16 125 $16.04 20,100 No 4 S Direct
Common Stock Acquisiton 2016-11-16 125 $10.73 20,225 No 4 M Direct
Common Stock Disposition 2016-11-16 125 $16.04 20,100 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Right to Buy Disposition 2016-11-16 334 $0.00 334 $5.92
Common Stock Stock Option Right to Buy Disposition 2016-11-16 125 $0.00 125 $8.58
Common Stock Stock Option Right to Buy Disposition 2016-11-16 125 $0.00 125 $10.73
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,833 2013-10-19 2020-09-19 No 4 M Direct
937 2014-03-06 2021-02-06 No 4 M Direct
1,750 2015-03-24 2022-02-24 No 4 M Direct
Footnotes
  1. This option was granted pursuant to IRIDEX Corporation's 2008 Equity Incentive Plan and is exempt to Rule 16b-3.
  2. The shares are subject to vesting according to the following schedule: 1/48th of the total number of shares vest each month.